Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cristina Sempio

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
British Journal of Clinical Pharmacology|December 16, 2025
Low-dose cannabidiol increases plasma concentrations of amitriptyline: A clinical drug-drug interaction studyAndriy A Gorbenko, Titiaan E Post, Pamela K Strugala, et al.
JMIR Dermatology|March 11, 2024
Oral Cannabidiol for Seborrheic Dermatitis in Patients With Parkinson Disease: Randomized Clinical TrialIsaac Weber, Caterina Zagona-Prizio, Torunn E Sivesind, et al.
Journal of Neuroinflammation|May 24, 2022
N-Oleoyl dopamine induces IL-10 via central nervous system TRPV1 and improves endotoxemia and sepsis outcomesJérémie Joffre, Erika Wong, Samira Lawton, et al.
Annals of Surgical Oncology|October 23, 2025
Cannabis, Pain, and Complications: A Prospective Analysis of Cannabis Use, Opiate Consumption, and Postoperative Outcomes following Cancer-Related Abdominal SurgeryElliott J Yee, Michael J Kirsch, Owen S Miller, et al.
Therapeutic Drug Monitoring|June 23, 2017
An Atmospheric Pressure Chemical Ionization MS/MS Assay Using Online Extraction for the Analysis of 11 Cannabinoids and Metabolites in Human Plasma and UrineJelena Klawitter, Cristina Sempio, Sophie Mörlein, et al.
International Journal of Environmental Research and Public Health|March 29, 2023
Associations between Prenatal and Postnatal Exposure to Cannabis with Cognition and Behavior at Age 5 Years: The Healthy Start StudyBrianna F Moore, Kaytlyn A Salmons, Adrienne T Hoyt, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 15, 2024
Short-Term Cannabidiol with Δ-9-Tetrahydrocannabinol in Parkinson's Disease: A Randomized TrialYing Liu, Jacquelyn Bainbridge, Stefan Sillau, et al.
Pediatric Obesity|December 16, 2024
Impact of prenatal exposure to delta 9-tetrahydrocannabinol and cannabidiol on birth size and postnatal growth trajectoriesBrianna F Moore, Noel T Mueller, Wei Perng, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 17, 2025
Effect of caffeine and cannabidiol (CBD) co-administration on Δ9-tetrahydrocannabinol (Δ9-THC) subjective effects, performance impairment, and pharmacokineticsJustin C Strickland, Hayleigh E Tilton, Noah M Patton, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
British Journal of Clinical Pharmacology|December 16, 2025
Low-dose cannabidiol increases plasma concentrations of amitriptyline: A clinical drug-drug interaction studyAndriy A Gorbenko, Titiaan E Post, Pamela K Strugala, et al.
JMIR Dermatology|March 11, 2024
Oral Cannabidiol for Seborrheic Dermatitis in Patients With Parkinson Disease: Randomized Clinical TrialIsaac Weber, Caterina Zagona-Prizio, Torunn E Sivesind, et al.
Journal of Neuroinflammation|May 24, 2022
N-Oleoyl dopamine induces IL-10 via central nervous system TRPV1 and improves endotoxemia and sepsis outcomesJérémie Joffre, Erika Wong, Samira Lawton, et al.
Annals of Surgical Oncology|October 23, 2025
Cannabis, Pain, and Complications: A Prospective Analysis of Cannabis Use, Opiate Consumption, and Postoperative Outcomes following Cancer-Related Abdominal SurgeryElliott J Yee, Michael J Kirsch, Owen S Miller, et al.
Therapeutic Drug Monitoring|June 23, 2017
An Atmospheric Pressure Chemical Ionization MS/MS Assay Using Online Extraction for the Analysis of 11 Cannabinoids and Metabolites in Human Plasma and UrineJelena Klawitter, Cristina Sempio, Sophie Mörlein, et al.
International Journal of Environmental Research and Public Health|March 29, 2023
Associations between Prenatal and Postnatal Exposure to Cannabis with Cognition and Behavior at Age 5 Years: The Healthy Start StudyBrianna F Moore, Kaytlyn A Salmons, Adrienne T Hoyt, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 15, 2024
Short-Term Cannabidiol with Δ-9-Tetrahydrocannabinol in Parkinson's Disease: A Randomized TrialYing Liu, Jacquelyn Bainbridge, Stefan Sillau, et al.
Pediatric Obesity|December 16, 2024
Impact of prenatal exposure to delta 9-tetrahydrocannabinol and cannabidiol on birth size and postnatal growth trajectoriesBrianna F Moore, Noel T Mueller, Wei Perng, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 17, 2025
Effect of caffeine and cannabidiol (CBD) co-administration on Δ9-tetrahydrocannabinol (Δ9-THC) subjective effects, performance impairment, and pharmacokineticsJustin C Strickland, Hayleigh E Tilton, Noah M Patton, et al.
Pageof 6